Protein Top-up Acceptability Study for Patients With Increased Protein Needs

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

October 28, 2020

Primary Completion Date

May 30, 2022

Study Completion Date

June 28, 2022

Conditions
CancerNeurological InjuryRespiratory DiseaseStroke
Interventions
OTHER

High protein liquid

After a 1-day baseline period to establish patients' acceptability, gastrointestinal tolerance, compliance, dietary intake while also capturing information related to user experience, risk of malnutrition, physical function, dietary intake, anthropometry and safety with their currently prescribed nutritional regimen, each patient will receive the high protein liquid daily for 28 days where the same measures will be replicated. The amount of the high protein liquid prescribed will always be completed by the patients' managing dietitian.

Trial Locations (2)

BN11 2DH

Western Sussex Hospitals NHS Trust, Worthing

BS2 8HW

University Hospitals Bristol, Bristol

All Listed Sponsors
lead

Nutricia UK Ltd

INDUSTRY

NCT04607330 - Protein Top-up Acceptability Study for Patients With Increased Protein Needs | Biotech Hunter | Biotech Hunter